- Elite Trade Club
- Posts
- IPO Spells Nearly 400% Success for This Trading Platform
IPO Spells Nearly 400% Success for This Trading Platform
Adam Garcia
April 14, 2025
Good Afternoon!
Hey, everyone. It's Adam from Elite Trade Club. Here’s what moved the market today.
High-Grade Resource (Sponsored)
On Behalf of Abitibi Metals
A $31M junior just posted nearly 1B lbs of copper equivalent.
With insiders and institutions piling in, this could be the next breakout.
[Full details here.]
*SGS Canada Inc. is responsible for the Technical Report. The Qualified Persons (“QPs”), as defined under NI 43-101, are Yann Camus, P.Eng., and Olivier Vadnais-Leblanc, P.Geo.
Markets 📈
The market started the week in good standing, allowing several U.S. indexes to rise. The Russell 2K small cap saw the most growth, adding over a percent to Friday’s score.
|
|
Market-Moving News 📈
Aerospace
Boeing Faces FAA Proposal to Modify Thousands of 737 Aircraft After Safety Incident
Boeing (NYSE: BA) may need to modify more than 2,600 U.S.-registered 737 aircraft after the Federal Aviation Administration (FAA) proposed an airworthiness directive related to cabin door latches. The action follows an incident where a passenger became trapped in a bathroom mid-flight, prompting an unscheduled landing.
FAA officials reviewed the mechanical issue and identified four latch part numbers linked to potential failure under certain conditions. Affected aircraft include the 737-700, 737-800, 737-900, 737-900ER, and 737 Max 8 and 9 models.
The agency’s proposal would require the replacement of the specified components, estimating a total cost of $3.4 million across the fleet. That figure includes labor and part expenses, with individual latches priced at up to $481. Depending on service agreements, operators may qualify for warranty coverage.
The FAA noted that a failure of the identified latch systems could delay emergency access in the event of turbulence or onboard medical events, particularly if cabin access is restricted.
Aircraft operators and industry stakeholders have until May 27 to respond to the proposed directive. Boeing has previously faced increased regulatory oversight involving its commercial aircraft programs, including the 737 family.
This latest directive forms part of routine airworthiness monitoring conducted by federal regulators.
Data-Driven Trades (Sponsored)
Discover the best days to consider trading top stocks like Apple, LULU, and Walmart.
These hotsheets are based on 10 years of historical data, giving you a clear edge. No confusing charts—just actionable trade opportunities.
Pharmaceuticals
Pfizer Discontinues Obesity Drug Trial, Refocuses Clinical Pipeline
Pfizer (NYSE: PFE) has officially ended a late-stage clinical trial of its oral GLP-1 candidate, danuglipron, after identifying a potential safety concern. The company confirmed that a participant in the phase III trial experienced a suspected liver-related adverse event, which subsided after treatment stopped.
Investigators monitored the safety profile throughout the trial before deciding to discontinue. The once-daily pill aimed to target the obesity and type 2 diabetes market, a space currently led by injectable treatments.
Clinical data showed elevated liver enzymes in isolated cases, prompting a complete evaluation of patient responses. Trial monitors implemented protocol-defined safety measures as soon as they identified the signal.
Pfizer had positioned danuglipron as its leading oral GLP-1 asset following the cancellation of a twice-daily formulation in 2023. Both candidates faced similar tolerability issues during testing.
Development teams redirected their focus toward other internal metabolic programs still under investigation. The company emphasized its ongoing commitment to advancing treatments in high-need therapeutic areas.
Regulatory filings reflect the study closure and will update ongoing pipeline communications. All participants received appropriate medical follow-up during the trial’s termination process.
Operational teams will adjust trial resources and timelines across impacted research sites. Pfizer remains active in multiple late-stage therapeutic categories beyond metabolic health, including oncology, immunology, and vaccines.
Top Stock Setups (Sponsored)
Want to know when to consider trading stocks like Apple and Walmart?
These Stock Hotsheets use 10 years of historical data to uncover key dates and trends—helping you trade with confidence
Utilities
Dominion Energy Seeks 14% Virginia Rate Increase, Captures Global Attention
Dominion Energy (NYSE: D) has requested a 14% electricity rate increase in Virginia, citing rising infrastructure costs tied to regional growth in energy demand. The filing, submitted to the Virginia State Corporation Commission, has drawn international media attention due to its scale and underlying drivers.
Coverage by global financial outlets followed Dominion’s explanation that upgrades are necessary to meet rising consumption from data centers and commercial expansion across Northern Virginia. Capital projects outlined in the filing include grid reinforcement, new substation construction, and increased system capacity.
Regulators will review Dominion’s proposal under the state’s cost-of-service model, which permits utilities to recover qualified investments and earn a regulated return. The requested adjustment would apply to residential and business customers in Dominion’s Virginia service territory if approved.
Company officials identified high-load commercial demand as a central factor behind recent investment activity. Under state law, new infrastructure enters the rate base once operational, affecting customer billing depending on asset class and depreciation schedules.
International coverage of the request has centered on the intersection of technology growth, energy infrastructure, and consumer cost allocation in utility-regulated markets.
Dominion continues to advance long-term infrastructure planning in line with demand projections and regulatory requirements.
Top Winners and Losers 🔥
Webull Corp [BULL] $XX (+XX%)
Webull more than quadrupled today after its shares went live through a recent SPAC merger.
US Rare Earth Inc [USAR] $XX (+XX%)
US Rare Earth came out a winner as Trump tariffs continue to upset the balance of materials out of countries like China.
Third Harmonic Bio Inc [THRD] $5.09 (+39.84%)
Third Harmonic rose to its highest in over two months as the company announced plans to liquidate all assets, including its lead drug candidate.
Children’s Place [PLCE] $5.75 (-15.27%)
Children’s apparel retailer Children's Place returns to the losers’ list as the company failed to impress investors with its Q4 and annual financial results released after markets closed on Friday.
MicroAlgo Inc [MLGO] $11.96 (-14.67%)
MicroAlgo dropped today despite previous bullish sentiment as tariff threats loom over the Chinese company.
Exodus Movement Inc [EXOD] $39.43 (-9.48%)
Exodus Movement remains in dire straits as sell-offs continue to lower the company’s share price.
Copper Breakout Watch (Sponsored)
On Behalf of Abitibi Metals
Billionaires. Bankers. Insiders.
Copper’s breaking out. This might be the next big one.
*SGS Canada Inc. is responsible for the Technical Report. The Qualified Persons (“QPs”), as defined under NI 43-101, are Yann Camus, P.Eng., and Olivier Vadnais-Leblanc, P.Geo.
That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!
Thanks for reading. I'll see you at the next open!
Best Regards,
— Adam G.
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
*Standard message/carrier rates may apply.
Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails.
